LRN and Nordic Business Ethics Initiative to collaborate with the 2023 survey
LRN Corporation, the leader in ethics and compliance solutions that enable organizations to inspire principled performance, today announces a collaboration with the Nordic Business Initiative (NBE) to deliver deeper insights into ethics and compliance (E&C) issues across the Nordic region.
LRN will be the exclusive provider of global E&C benchmarking data to NBE, which will give additional global context to the organization’s bi-annual ‘Nordic Ethics & Compliance Survey’ for the first time.
Nordic Ethics & Compliance Survey reports on trends in the state of ethics & compliance programs in the Nordic region. It analyzes data relating to internal Ethics & Compliance work in Nordic organisations. The survey responses are gathered from Denmark, Finland, Norway and Sweden.
LRN is an authoritative voice on global E&C issues and will provide key data insights and benchmarking from its world-leading 2023 Program Effectiveness Report, as well as previously unpublished insights from its full data set. The report is based on responses from more than 1,850 E&C professionals at organizations across 26 industries and in 10 different countries – the largest and most comprehensive research of its kind.
In addition to providing this extra global perspective to the NBE survey, experts from LRN will also be taking part in an event series alongside prominent speakers from NBE and other leading regional ethics and compliance experts examining the survey findings and exploring key themes and topical issues. The event series will take place after the publication of the full NBE report in November.
“The Nordic Business Ethics Initiative is doing vital work in building awareness of ethics and compliance across the Nordic region, and its research is a critical tool when it comes to understanding the state of play so that key issues can be addressed,” said Kevin Michielsen, CEO of LRN. “Our collaboration with NBE will give this important study a valuable extra dimension. For businesses across the Nordic region, including Nordic-based multi-national companies, it’s important to consider ethics and compliance issues against the global backdrop that takes account of geo-political developments, emerging challenges, and ongoing crises. The incorporation of our global data will help benchmark the performance of companies in the Nordics against their peers around the world and enable even better understanding the impact and efficacy of E&C programs.”
NBE co-founder Niina Ratsula added, “Being able to incorporate insights from LRN’s market-leading dataset into our 2023 Nordic Ethics & Compliance Survey report will give it, and our NBE members, even more value. By putting our findings around what’s happening in the Nordic region into the bigger, international picture, our research will have deeper meaning, so that organizations can see not just how the issues are developing around them, but what’s happening further afield too.”
Companies across the Nordic region are encouraged to participate in this year’s NBE survey by visiting: https://www.nordicbusinessethics.com/nordic-ethics-compliance-survey-2023/.
ENDS
Notes to Editors:
About LRN
LRN's mission and purpose is to inspire principled performance and help people around the world do the right thing. Since 1994, LRN has worked to propel organizations forward with the partnership, knowledge, and tools to build ethical culture. More than 2,800 companies and tens of millions of learners worldwide utilize LRN services and take LRN e-learning courses to help navigate complex regulatory environments and foster ethical, responsible, and inclusive cultures. In partnership with LRN, companies translate their values into concrete corporate practices and leadership behaviors that create sustainable competitive advantage. By acting upon shared values, companies and their people find the means to outbehave and outperform. Learn more at LRN.com and follow on Twitter, LinkedIn, and Facebook.
About the Nordic Business Ethics Initiative
The Nordic Business Ethics Initiative was created to build stronger and more responsible organizations. Its ambition is to promote responsible business conduct and support business leaders and professionals through sharing lessons learned, building best practices and facilitating dialogue and networking. The initiative consists of various activities, all aiming to raise awareness of what business ethics is and provide tools to create ethical, compliant workplaces.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230830345702/en/
Contact information
Media
Scott Addison, Charlotte Hole and Gabriel Oben, Infinite Global (for LRN Corporation)
LRN@infiniteglobal.com
Niina Ratsula, Co-Founder of Nordic Business Ethics Initiative, niina@nordicbusinessethics.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
